Skip to main content
Premium Trial:

Request an Annual Quote

Bucher to Distribute Fluxion's Cell Analysis Tools in Switzerland

NEW YORK (GenomeWeb News) – Cellular analysis toolmaker Fluxion Biosciences said yesterday that it has hired Bucher Biotec to sell and distribute its research tools to drug developers in Switzerland.
 
Under the exclusive agreement, Basel-based Bucher will distribute Fluxion’s BioFlux cell imaging analysis tools.
 
The BioFlux 200 is used in cell adhesion and microbial biofilm studies and allows researchers to study live cells and biofilms under controlled conditions.
 
Financial terms of the agreement were not released.